SRX sierra rutile holdings limited

Sirt result

  1. 189 Posts.
    My thought are.
    No trifecta but a very good Double.
    1/Response rate was Higher with sirt by 7.4%
    2/Both the side effect profile and QUALITY OF LIFE was much better over time in the sirt group.
    3/ if patient Re not tolerant or have contraindications for Sorafenib therapy there are currently no standard of care .

    Paragraph 2 an 3 is the key for me.

    Yes i get it the primary end point did not show an overall survival superiority

    I the end quality of life is far more important.

    Glta
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.